Dr Andrew Partington will draw upon the emerging best practices in early and development-focused Health Technology Assessment (HTA), to present and discuss with the audience how economic evidence can be used within the development of products and services. He will navigate how different methods and data sources are best used, and address the importance of differing economic perspectives and the characterisation of decision-uncertainty. Finally, he will highlight other evidence-consideration and decision-making processes that exist, in addition to HTA, across the health economy.
Resource Documents
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
